Download PDF
Clin Colon Rectal Surg 2009; 22(4): 209-217
DOI: 10.1055/s-0029-1242460
© Thieme Medical Publishers

Screening Options and Recommendations for Colorectal Cancer

Timothy M. Geiger1 , Rocco Ricciardi1
  • 1Department of Colon and Rectal Surgery, Lahey Clinic, Burlington, Massachusetts
Further Information

Publication History

Publication Date:
06 November 2009 (online)

    Permissions and Reprints

ABSTRACT

Screening reduces the burden of disease from colorectal cancer through early detection of cancerous lesions and removal of precancerous polyps. The ideal colorectal cancer screening modality should be cost-effective, increase life-years gained, permit long intervals between tests with high patient compliance and low risk to the patient. Although no single colorectal cancer screening method is perfect, several options exist. Government agencies and medical societies have published screening recommendations with differing guidelines; yet, despite the lack of a consistent standard, it is clear that colorectal cancer screening is cost-effective. In this review, the authors address several options for screening, identify risks and benefits, and present methods to risk stratify patients. A thorough discussion with the patient about potential benefits and harms is critical before initiating any screening regimen.

KEYWORDS

Screening - colorectal cancer - colonoscopy - fecal occult blood test - virtual colonoscopy

REFERENCES

  • 1 Jemal A, Siegel R, Ward E et al.. Cancer statistics, 2008.  CA Cancer J Clin. 2008;  58(2) 71-96
    CrossrefPubMedGoogle Scholar
  • 2 Geiger T M, Miedema B W, Geana M V, Thaler K, Rangnekar N J, Cameron G T. Improving rates for screening colonoscopy: Analysis of the health information national trends survey (HINTS I) data.  Surg Endosc. 2008;  22(2) 527-533
    CrossrefPubMedGoogle Scholar
  • 3 Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.  Am J Gastroenterol. 2008;  103(6) 1541-1549
    CrossrefPubMedGoogle Scholar
  • 4 Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.  Gastroenterology. 2005;  129(2) 422-428
    CrossrefPubMedGoogle Scholar
  • 5 Allison J E, Sakoda L C, Levin T R et al.. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.  J Natl Cancer Inst. 2007;  99 1462-1470
    PubMedGoogle Scholar
  • 6 Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis.  Cell. 1990;  61(5) 759-767
    CrossrefPubMedGoogle Scholar
  • 7 Ahlquist D A, Skoletsky J E, Boynton K A et al.. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.  Gastroenterology. 2000;  119(5) 1219-1227
    CrossrefPubMedGoogle Scholar
  • 8 Tagore K S, Lawson M J, Yucaitis J A et al.. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.  Clin Colorectal Cancer. 2003;  3(1) 47-53
    CrossrefPubMedGoogle Scholar
  • 9 Calistri D, Rengucci C, Bocchini R, Saragoni L, Zoli W, Amadori D. Fecal multiple molecular tests to detect colorectal cancer in stool.  Clin Gastroenterol Hepatol. 2003;  1(5) 377-383
    CrossrefPubMedGoogle Scholar
  • 10 Imperiale T F, Ransohoff D F, Itzkowitz S H, Turnbull B A, Ross M E. Colorectal Cancer Study Group . Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.  N Engl J Med. 2004;  351(26) 2704-2714
    CrossrefPubMedGoogle Scholar
  • 11 Syngal S, Stoffel E, Chung D et al.. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.  Cancer. 2006;  106(2) 277-283
    CrossrefPubMedGoogle Scholar
  • 12 Duffy M J, van Dalen A, Haglund C et al.. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.  Eur J Cancer. 2003;  39(6) 718-727
    CrossrefPubMedGoogle Scholar
  • 13 Kim H J, Yu M H, Kim H, Byun J, Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer.  BMB Rep. 2008;  41 685-692
    PubMedGoogle Scholar
  • 14 Winawer S, Stewart E, Zauber A et al.. A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group.  N Engl J Med. 2000;  342 1766-1772
    CrossrefPubMedGoogle Scholar
  • 15 Rex D K, Rahmani E Y, Haseman J H, Lemmel G T, Kaster S, Buckley J S. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice.  Gastroenterology. 1997;  112(1) 17-23
    CrossrefPubMedGoogle Scholar
  • 16 Levin B, Lieberman D A, McFarland B American Cancer Society Colorectal Cancer Advisory Group et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.  Gastroenterology. 2008;  134(5) 1570-1595
    CrossrefPubMedGoogle Scholar
  • 17 Cotton P B, Durkalski V L, Pineau B C et al.. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia.  JAMA. 2004;  291 1713-1719
    CrossrefPubMedGoogle Scholar
  • 18 Rockey D C, Paulson E, Niedzwiecki D et al.. Analysis of air contrast barium enema, computed tomographic colonography and colonoscopy: prospective comparison.  Lancet. 2005;  365 305-311
    CrossrefPubMedGoogle Scholar
  • 19 Pickhardt P J, Choi J R, Hwang I et al.. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.  N Engl J Med. 2003;  349 2191-2000
    CrossrefPubMedGoogle Scholar
  • 20 Johnson C D, Harmsen W S, Wilson L A et al.. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps.  Gastroenterology. 2003;  125(2) 311-319
    CrossrefPubMedGoogle Scholar
  • 21 Kim D H, Pickhardt P J, Taylor A J et al.. CT colonography versus colonoscopy for the detection of advanced neoplasia.  N Engl J Med. 2007;  357(14) 1403-1412
    CrossrefPubMedGoogle Scholar
  • 22 Halligan S, Altman D G, Taylor S A et al.. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting.  Radiology. 2005;  237(3) 893-904
    CrossrefPubMedGoogle Scholar
  • 23 Newcomb P A, Norfleet R G, Storer B E, Surawicz T S, Marcus P M. Screening sigmoidoscopy and colorectal cancer mortality.  J Natl Cancer Inst. 1992;  84(20) 1572-1575
    CrossrefPubMedGoogle Scholar
  • 24 Gross C P, Andersen M S, Krumholz H M, McAvay G J, Proctor D, Tinetti M E. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.  JAMA. 2006;  296(23) 2815-2822
    CrossrefPubMedGoogle Scholar
  • 25 Mandel J S, Church T R, Bond J H et al.. The effect of fecal occult-blood screening on the incidence of colorectal cancer.  N Engl J Med. 2000;  343(22) 1603-1607
    CrossrefPubMedGoogle Scholar
  • 26 Thiis-Evensen E, Hoff G, Sauar J et al.. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark polyp study I.  Scand J Gastroenterol. 1999;  34 414-420
    CrossrefPubMedGoogle Scholar
  • 27 Singh H, Turner D, Xue L, Targownik L E, Bernstein C N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.  JAMA. 2006;  295(20) 2366-2373
    CrossrefPubMedGoogle Scholar
  • 28 Winawer S J, Zauber A G, Ho M N The National Polyp Study Work Group et al. Prevention of colorectal cancer by colonoscopic polypectomy.  N Engl J Med. 1993;  329(27) 1977-1981
    CrossrefPubMedGoogle Scholar
  • 29 Rex D K, Cutler C S, Lemmel G T et al.. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies.  Gastroenterology. 1997;  112(1) 24-28
    CrossrefPubMedGoogle Scholar
  • 30 Pickhardt P J, Nugent P A, Mysliwiec P A, Choi J R, Schindler W R. Location of adenomas missed by optical colonoscopy.  Ann Intern Med. 2004;  141(5) 352-359
    CrossrefPubMedGoogle Scholar
  • 31 Barclay R L, Vicari J J, Doughty A S, Johanson J F, Greenlaw R L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.  N Engl J Med. 2006;  355(24) 2533-2541
    CrossrefPubMedGoogle Scholar
  • 32 Johnson C D, Chen M H, Toledano A Y et al.. Accuracy of CT colonography for detection of large adenomas and cancers.  N Engl J Med. 2008;  359(12) 1207-1217
    CrossrefPubMedGoogle Scholar
  • 33 Cotterill M, Gasparelli R, Kirby E. Colorectal cancer detection in a rural community. Development of a colonoscopy screening program.  Can Fam Physician. 2005;  51 1224-1228
    PubMedGoogle Scholar
  • 34 Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer.  Dis Colon Rectum. 1996;  39(6) 676-680
    CrossrefPubMedGoogle Scholar
  • 35 Ko C, Riffle S, Morris C et al.. Complications after screening and surveillance colonoscopy [Abstract].  Gastroenterology. 2007;  132 A149
    PubMedGoogle Scholar
  • 36 Ko C W, Riffle S, Shapiro J A et al.. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy.  Gastrointest Endosc. 2007;  65(4) 648-656
    CrossrefPubMedGoogle Scholar
  • 37 Levin T R, Zhao W, Conell C et al.. Complications of colonoscopy in an integrated health care delivery system.  Ann Intern Med. 2006;  145(12) 880-886
    CrossrefPubMedGoogle Scholar
  • 38 Nelson D B, McQuaid K R, Bond J H, Lieberman D A, Weiss D G, Johnston T K. Procedural success and complications of large-scale screening colonoscopy.  Gastrointest Endosc. 2002;  55(3) 307-314
    CrossrefPubMedGoogle Scholar
  • 39 Rathgaber S W, Wick T M. Colonoscopy completion and complication rates in a community gastroenterology practice.  Gastrointest Endosc. 2006;  64(4) 556-562
    CrossrefPubMedGoogle Scholar
  • 40 Robinson M H, Hardcastle J D, Moss S M et al.. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.  Gut. 1999;  45(4) 588-592
    CrossrefPubMedGoogle Scholar
  • 41 Segnan N, Senore C, Andreoni B SCORE Working Group--Italy et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE.  J Natl Cancer Inst. 2002;  94(23) 1763-1772
    CrossrefPubMedGoogle Scholar
  • 42 Atkin W S, Hart A, Edwards R et al.. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening.  Gut. 1998;  42(4) 560-565
    CrossrefPubMedGoogle Scholar
  • 43 Jain A, Falzarano J, Jain A, Decker R, Okubo G, Fujiwara D. Outcome of 5,000 flexible sigmoidoscopies done by nurse endoscopists for colorectal screening in asymptomatic patients.  Hawaii Med J. 2002;  61(6) 118-120
    PubMedGoogle Scholar
  • 44 Levin T R, Conell C, Shapiro J A, Chazan S G, Nadel M R, Selby J V. Complications of screening flexible sigmoidoscopy.  Gastroenterology. 2002;  123(6) 1786-1792
    CrossrefPubMedGoogle Scholar
  • 45 Davila R E, Rajan E, Baron T H Standards of Practice Committee, American Society for Gastrointestinal Endoscopy et al. ASGE guideline: colorectal cancer screening and surveillance.  Gastrointest Endosc. 2006;  63(4) 546-557
    CrossrefPubMedGoogle Scholar
  • 46 Vasen H F, Nagengast F M, Khan P M. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome).  Lancet. 1995;  345 1183-1184
    CrossrefPubMedGoogle Scholar
  • 47 Konda A, Duffy M.. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.  Gastroenterol Clin North Am. 2008;  37 191-213
    CrossrefPubMedGoogle Scholar
  • 48 Thornton J G, Morris A M, Thornton J D, Flowers C R, McCashland T M. Racial variation in colorectal polyp and tumor location.  J Natl Med Assoc. 2007;  99(7) 723-728
    PubMedGoogle Scholar
  • 49 Imperiale T F, Wagner D R, Lin C Y, Larkin G N, Rogge J D, Ransohoff D F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.  N Engl J Med. 2000;  343(3) 169-174
    CrossrefPubMedGoogle Scholar
  • 50 Anderson J C, Alpern Z, Messina C R et al.. Predictors of proximal neoplasia in patients without distal adenomatous pathology.  Am J Gastroenterol. 2004;  99(3) 472-477
    CrossrefPubMedGoogle Scholar
  • 51 Betes Ibanez M, Munoz-Navas M A, Duque J M et al.. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy.  Gastrointest Endosc. 2004;  59(6) 634-641
    CrossrefPubMedGoogle Scholar
  • 52 Zauber A, Lansdrop-Vogelaar I, Knudsen A et al.. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force.  Ann Intern Med. 2008;  149 659-669
    CrossrefPubMedGoogle Scholar
  • 53 Gross C P, McAvay G J, Krumholz H M, Paltiel A D, Bhasin D, Tinetti M E. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.  Ann Intern Med. 2006;  145(9) 646-653
    PubMedGoogle Scholar
  • 54 U.S. Preventive Services Task Force . Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.  Ann Intern Med. 2008;  149(9) 627-637
    PubMedGoogle Scholar
  • 55 Levin B, Lieberman D A, McFarland B American Cancer Society Colorectal Cancer Advisory Group et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.  Gastroenterology. 2008;  134(5) 1570-1595
    CrossrefPubMedGoogle Scholar

Rocco RicciardiM.D. M.P.H. 

Department of Colon and Rectal Surgery, Lahey Clinic

41 Mall Rd., Burlington, MA 01805

Email: Rocco.ricciardi@Lahey.org

      >